ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jerrold H. Levy
G. Michael Deeb
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, J. H.
Right arrow Articles by Deeb, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, J. H.
Right arrow Articles by Deeb, G. M.
Related Collections
Right arrow Anesthesia

Ann Thorac Surg 2002;73:325-330
© 2002 The Society of Thoracic Surgeons


Review

Intravenous milrinone in cardiac surgery

Jerrold H. Levy, MD*a, James M. Bailey, MD, PhDa, G. Michael Deeb, MDb

a Division of Cardiothoracic Anesthesiology and Critical Care, The Emory Clinic, Emory University School of Medicine and Emory Healthcare, Atlanta, Georgia, USA
b Division of Cardiothoracic Surgery, The University of Michigan, Ann Arbor, Michigan, USA

* Address reprint requests to Dr Levy, Emory University Hospital, 1364 Clifton Rd, NE, Atlanta, GA 30322, USA
e-mail: jerrold_levy{at}emory.org

Phosphodiesterase inhibitors including milrinone produce positive inotropic effects by slowing the hydrolysis of cyclic adenosine monophosphate in the myocardium. With a loading dose of 50 µg/kg followed by an infusion of 0.5 µg · kg-1 · min-1, milrinone increases stroke volume index and left ventricular velocity of circumferential fiber shortening after weaning from cardiopulmonary bypass. Milrinone has potential for the treatment and prevention of internal mammary artery spasm because of its vasodilative effect, which is similar to that of papaverine, and is a potent pulmonary vasodilator for patients with right ventricular dysfunction and pulmonary vasoconstriction. Low-dose milrinone may have anti-inflammatory properties and potentially can improve splanchnic perfusion.




This article has been cited by other articles:


Home page
Card Surg AdultHome page
J. H. Levy, K. A. Tanaka, and J. M. Bailey
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2008; 3(2008): 77 - 110.
[Full Text]


Home page
J. Biol. Chem.Home page
S.-H. Hung, W. Zhang, R. A. Pixley, B. A. Jameson, Y. C. Huang, R. F. Colman, and R. W. Colman
New Insights from the Structure-Function Analysis of the Catalytic Region of Human Platelet Phosphodiesterase 3A: A ROLE FOR THE UNIQUE 44-AMINO ACID INSERT
J. Biol. Chem., September 29, 2006; 281(39): 29236 - 29244.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. M. Bailey, K. A. Tanaka, and J. H. Levy
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118.
[Full Text]


Home page
Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.